Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis: Multicenter, Open-label, Non-inferiority, Randomized Controlled Study

NCT07546097 is registered in ClinicalTrials.gov with Yongquan Shi as lead sponsor.

NCT NCT07546097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07546097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis: Multicenter, Open-label, Non-inferiority, Randomized Controlled Study
Lead sponsor
Yongquan Shi
Phase
Phase 4
Overall status
Recruiting
Start date
March 23, 2026
Completion date
June 30, 2027
Enrollment
46 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute severe ulcerative colitis